ArticleOncotarget2016

Salinomycin exerts anti-angiogenic and anti-tumorigenic activities by inhibiting vascular endothelial growth factor receptor 2-mediated angiogenesis.

Tao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.